Therapeutic use of regulatory T cells for graft‐versus‐host disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic use of regulatory T cells for graft‐versus‐host disease
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 187, Issue 1, Pages 25-38
Publisher
Wiley
Online
2019-08-16
DOI
10.1111/bjh.16157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bim regulates the survival and suppressive capability of CD8+FOXP3+regulatory T cells during murine GVHD
- (2018) Kimberle Agle et al. BLOOD
- TCR Transgenic Mice Reveal Stepwise, Multi-site Acquisition of the Distinctive Fat-Treg Phenotype
- (2018) Chaoran Li et al. CELL
- A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
- (2018) Eleonora Trotta et al. NATURE MEDICINE
- The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease
- (2018) Cameron McDonald-Hyman et al. JOURNAL OF CLINICAL INVESTIGATION
- Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease
- (2018) Supinya Iamsawat et al. JOURNAL OF IMMUNOLOGY
- Treg cells—the next frontier of cell therapy
- (2018) Jeffrey A. Bluestone et al. SCIENCE
- IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
- (2017) Brian C. Betts et al. HAEMATOLOGICA
- Stability and function of regulatory T cells expressing the transcription factor T-bet
- (2017) Andrew G. Levine et al. NATURE
- Combined OX40L and mTOR blockade controls effector T cell activation while preserving T reg reconstitution after transplant
- (2017) Victor Tkachev et al. Science Translational Medicine
- IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
- (2017) Brian C. Betts et al. HAEMATOLOGICA
- Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects
- (2017) Grégory Ehx et al. OncoImmunology
- TNF-α priming enhances CD4 + FoxP3 + regulatory T-cell suppressive function in murine GVHD prevention and treatment
- (2016) Antonio Pierini et al. BLOOD
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
- (2016) Katherine G. MacDonald et al. JOURNAL OF CLINICAL INVESTIGATION
- Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
- (2016) Martin Chopra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Induced Regulatory T Cells: Their Development, Stability, and Applications
- (2016) Mitsuhiro Kanamori et al. TRENDS IN IMMUNOLOGY
- Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
- (2015) Charlotte R. Grant et al. AUTOIMMUNITY REVIEWS
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
- (2015) C. G. Brunstein et al. BLOOD
- Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease
- (2015) Anke Theil et al. CYTOTHERAPY
- Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease
- (2015) Antonio Pierini et al. JOURNAL OF IMMUNOLOGY
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease
- (2015) Mareike Florek et al. PLoS One
- Superiority of Rapamycin Over Tacrolimus in Preserving Nonhuman Primate Treg Half-Life and Phenotype After Adoptive Transfer
- (2014) K. Singh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
- (2014) S. Ganguly et al. BLOOD
- Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo
- (2014) S. Parmar et al. BLOOD
- HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
- (2014) M. F. Martelli et al. BLOOD
- Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
- (2014) G. Lal et al. JOURNAL OF IMMUNOLOGY
- Adoptive Transfer of Umbilical Cord Blood-Derived Regulatory T Cells and Early Viral Reactivation
- (2013) Claudio G. Brunstein et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice
- (2013) Gaëlle H. Martin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant
- (2013) Z. McIver et al. HAEMATOLOGICA
- Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo
- (2013) P. Zhang et al. JOURNAL OF IMMUNOLOGY
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Human CD8+ Regulatory T Cells Inhibit GVHD and Preserve General Immunity in Humanized Mice
- (2013) J. Zheng et al. Science Translational Medicine
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
- (2013) Yoshiaki Okubo et al. Scientific Reports
- Cell-autonomous role of TGF and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD
- (2012) N. Sawamukai et al. BLOOD
- Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
- (2012) O. C. Goodyear et al. BLOOD
- Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation
- (2012) R. J. Robb et al. BLOOD
- Frequency of CD4+FOXP3+ regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD
- (2012) T Fujioka et al. BONE MARROW TRANSPLANTATION
- Can Treg therapy prevent GVHD?
- (2011) K. V. Komanduri et al. BLOOD
- Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
- (2011) H.-J. Shin et al. BLOOD
- Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly
- (2011) A. Veerapathran et al. BLOOD
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- High frequencies of CD62L+ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation
- (2011) S-Y. Lu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease
- (2011) A. Beres et al. CLINICAL CANCER RESEARCH
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity
- (2011) K. L. Hippen et al. Science Translational Medicine
- Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4+CD25highCD127low/− regulatory T cells
- (2010) Sya N. Ukena et al. ANNALS OF HEMATOLOGY
- Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease
- (2010) John M. Magenau et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Blood and Gastric FOXP3+ T Cells Are Not Decreased in Human Gastric Graft-versus-Host Disease
- (2010) James D. Lord et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without Abrogating the Graft-versus-Leukemia Effect in Murine Models
- (2010) Omar Duramad et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses
- (2010) C. Vogtenhuber et al. BLOOD
- In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
- (2010) J. Choi et al. BLOOD
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation
- (2010) Qing Li et al. LEUKEMIA RESEARCH
- Increase in FOXP3+ Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response
- (2009) Cristina Fondi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced Frequency of Regulatory T Cells in Peripheral Blood Stem Cell Compared to Bone Marrow Transplantations
- (2009) Céline Blache et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease
- (2009) X. Chen et al. BLOOD
- Immunomagnetic isolation of CD4+CD25+FoxP3+natural T regulatory lymphocytes for clinical applications
- (2009) M. Di Ianni et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Alloantigen-specificde novo-induced Foxp3+Treg revertin vivoand do not protect from experimental GVHD
- (2009) Christian Koenecke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
- (2009) James L. Riley et al. IMMUNITY
- Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells
- (2008) K. L. Hippen et al. BLOOD
- In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease
- (2008) D. Zhao et al. BLOOD
- Comparative Study of Regulatory T Cell Function of HumanCD25+CD4+T Cells from Thymocytes, Cord Blood, and Adult Peripheral Blood
- (2008) Wakae Fujimaki et al. Clinical & Developmental Immunology
- Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells
- (2008) G. Noël et al. CLINICAL IMMUNOLOGY
- Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
- (2008) A. L. Putnam et al. DIABETES
- DNA methylation controls Foxp3 gene expression
- (2008) Julia K. Polansky et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127pos Depletion, Treg Expansion, and Treg Cryopreservation
- (2008) Jorieke H. Peters et al. PLoS One
- Regulatory T Cells: Mechanisms of Differentiation and Function
- (2007) Steven Z. Josefowicz et al. Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started